| module: |
BL4216 Structure-based drug discovery |
| taken in: |
Seniour Honours Year,
semester 2
|
| value: |
15 credits |
| description: |
The process of developing a new drug from conception to the clinic takes on average 15 years and costs over $800M. There are now many examples of drugs developed based on a knowledge of the three dimensional structure of the target, and all major pharmaceutical companies have structural biology as part of their core drug discovery programmes. Many drugs currently used to combat AIDS were developed from a detailed knowledge of key HIV proteins, as were the two drugs used for influenza. Most major pharmaceutical companies are targeting kinases in the search for new cancer therapies, with international efforts focusing on producing structural details of huge numbers of human kinases.
This module will examine case studies of drugs that have been developed with the aid of structure-based methods
|
| organiser: |
Dr Rupert Russell - (click name for profile) |
| poster: |
pdf available |
| see also: |
.
|
BL4216 is an option in all of these degree programmes:
click the degree name to browse all module options for that programme |
Biochemistry
Biology
Biology - joint degrees
Cell Biology
Molecular Biology
Biology and Psychology
Psychology with Biology
|